Peter Sartipy

5.6k total citations · 1 hit paper
74 papers, 3.6k citations indexed

About

Peter Sartipy is a scholar working on Molecular Biology, Biomedical Engineering and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Sartipy has authored 74 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 19 papers in Biomedical Engineering and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Sartipy's work include Pluripotent Stem Cells Research (31 papers), 3D Printing in Biomedical Research (16 papers) and CRISPR and Genetic Engineering (14 papers). Peter Sartipy is often cited by papers focused on Pluripotent Stem Cells Research (31 papers), 3D Printing in Biomedical Research (16 papers) and CRISPR and Genetic Engineering (14 papers). Peter Sartipy collaborates with scholars based in Sweden, United States and Netherlands. Peter Sartipy's co-authors include David J. Loskutoff, Eva Hurt‐Camejo, Germán Camejo, Jane Synnergren, Johan Hyllner, Petter Björquist, Anders Lindahl, Birgitta Rosengren, Berit Johansen and Caroline Améen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Peter Sartipy

73 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monocyte chemoattractant protein 1 in obesity and insulin resistance

2003 935 citations Peter Sartipy et al. profile →

Peers

Countries citing papers authored by Peter Sartipy

Since Specialization

Citations

This map shows the geographic impact of Peter Sartipy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sartipy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sartipy more than expected).

Fields of papers citing papers by Peter Sartipy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sartipy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sartipy. The network helps show where Peter Sartipy may publish in the future.

Co-authorship network of co-authors of Peter Sartipy

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Sartipy. A scholar is included among the top collaborators of Peter Sartipy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Sartipy. Peter Sartipy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unraveling the Metabolic Derangements Occurring in Non-infarcted Areas of Pig Hearts With Chronic Heart Failure 2021 ·Frontiers in Cardiovascular Medicine ·Cláudia Correia, Qing‐Dong Wang, (unknown), Leif Carlsson, Benjamin Ulfenborg, Anna Walentinsson, (unknown), Margareta Behrendt, Johannes Wikström, Peter Sartipy, Karin Jennbacken, Jane Synnergren	1
2	Correction of anemia by dapagliflozin in patients with type 2 diabetes 2020 ·Journal of Diabetes and its Complications ·Bergur V. Stefánsson, Hiddo J.L. Heerspink, David C. Wheeler, C. David Sjöström, Peter J. Greasley, Peter Sartipy, Valerie A. Cain, Ricardo Correa‐Rotter	32
3	Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials 2019 ·Journal of Diabetes and its Complications ·Robert D. Toto, Ronald Goldenberg, Glenn M. Chertow, Valerie A. Cain, Bergur V. Stefánsson, C. David Sjöström, Peter Sartipy	33
4	Dapagliflozin in patients with type II diabetes mellitus, with and without elevated triglyceride and reduced high-density lipoprotein cholesterol levels 2017 ·Journal of clinical lipidology ·Harold Bays, Peter Sartipy, John Xu, C. David Sjöström, James Underberg	27
5	Highly Synchronized Expression of Lineage‐Specific Genes during In Vitro Hepatic Differentiation of Human Pluripotent Stem Cell Lines 2016 ·Stem Cells International ·(unknown), Björn Olsson, Josefina Edsbagge, Barbara Küppers-Munther, (unknown), Annika Asplund, Tommy B. Andersson, Petter Björquist, Helena Carén, Stina Simonsson, Peter Sartipy, Jane Synnergren	13
6	High Content Analysis of Human Pluripotent Stem Cell Derived Hepatocytes Reveals Drug Induced Steatosis and Phospholipidosis 2016 ·Stem Cells International ·(unknown), Daniella Steel, (unknown), Gustav Holmgren, Magnus Ingelman‐Sundberg, Peter Sartipy, Petter Björquist, Inger Johansson, Josefina Edsbagge	29
7	Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes 2014 ·Drug Metabolism and Disposition ·Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragán, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman‐Sundberg, Tommy B. Andersson, Josefina Edsbagge	76
8	Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells 2014 ·Toxicology ·Gustav Holmgren, Jane Synnergren, Yalda Bogestål, Caroline Améen, (unknown), (unknown), Anders Lindahl, Peter Sartipy	66
9	A Novel 3D Label-Free Monitoring System of hES-Derived Cardiomyocyte Clusters: A Step Forward to In Vitro Cardiotoxicity Testing 2013 ·PLoS ONE ·Heinz‐Georg Jahnke, Daniella Steel, (unknown), Diana Seidel, (unknown), (unknown), (unknown), Peter Sartipy, Andrea A. Robitzki	25
10	Advancing Pluripotent Stem Cell Culture: It Is a Matter of Setting the Standard 2013 ·Stem Cells and Development ·Peter Sartipy	3
11	Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes 2010 ·Stem Cell Research ·Malin K.B. Jonsson, Göran Duker, (unknown), (unknown), Peter Sartipy, Marc A. Vos, Toon A.B. van Veen	48
12	Differentiation of Human Embryonic Stem Cells to Cardiomyocytes for In Vitro and In Vivo Applications 2010 ·Stem Cell Reviews and Reports ·Hilmar Viđarsson, Johan Hyllner, Peter Sartipy	80
13	Transcriptional Profiling of Human Embryonic Stem Cells Differentiating to Definitive and Primitive Endoderm and Further Toward the Hepatic Lineage 2009 ·Stem Cells and Development ·Jane Synnergren, Nico Heins, Gabriella Brolén, (unknown), Anders Lindahl, Johan Hyllner, Björn Olsson, Peter Sartipy, Petter Björquist	13
14	Low molecular weight compounds for in vitro fate determination of human embryonic stem cells 2008 ·Pharmacological Research ·Peter Sartipy, Raimund Strehl, Petter Björquist, Johan Hyllner	6
15	New cell models and assays in cardiac safety profiling 2007 ·Expert Opinion on Drug Metabolism & Toxicology ·Thomas Meyer, Peter Sartipy, (unknown), (unknown), Elke Guenther	25
16	Human embryonic stem cells: Current technologies and emerging industrial applications 2007 ·Critical Reviews in Oncology/Hematology ·Caroline Améen, Raimund Strehl, Petter Björquist, Anders Lindahl, Johan Hyllner, Peter Sartipy	64
17	New cell models and assays in cardiac safety profiling 2007 ·Expert Opinion on Drug Metabolism & Toxicology ·Thomas Meyer, Peter Sartipy, (unknown), (unknown), Elke Guenther	27
18	Phospholipase A2 Modification of Lipoproteins: Potential Effects on Atherogenesis 2002 ·Advances in experimental medicine and biology ·Peter Sartipy, Germán Camejo, Lennart Svensson, Eva Hurt‐Camejo	10
19	Phospholipase A2 and small, dense low-density lipoprotein 2000 ·Current Opinion in Lipidology ·Eva Hurt‐Camejo, Germán Camejo, Peter Sartipy	76
20	Binding of Human Phospholipase A2 Type II to Proteoglycans 1996 ·Journal of Biological Chemistry ·Peter Sartipy, Berit Johansen, Germán Camejo, Birgitta Rosengren, Göran Bondjers, Eva Hurt‐Camejo	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact